ModivCare EBITDA Margin 2010-2025 | MODV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ModivCare (MODV) over the last 10 years. The current EBITDA margin for ModivCare as of March 31, 2025 is .
| ModivCare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.75B | $0.13B | 4.65% |
| 2024-12-31 | $2.79B | $0.13B | 4.63% |
| 2024-09-30 | $2.78B | $0.14B | 5.03% |
| 2024-06-30 | $2.77B | $0.14B | 5.20% |
| 2024-03-31 | $2.77B | $0.14B | 5.16% |
| 2023-12-31 | $2.75B | $0.15B | 5.56% |
| 2023-09-30 | $2.70B | $0.14B | 5.29% |
| 2023-06-30 | $2.66B | $0.14B | 5.37% |
| 2023-03-31 | $2.59B | $0.16B | 6.09% |
| 2022-12-31 | $2.51B | $0.16B | 6.51% |
| 2022-09-30 | $2.43B | $0.17B | 7.00% |
| 2022-06-30 | $2.27B | $0.16B | 6.91% |
| 2022-03-31 | $2.12B | $0.15B | 6.95% |
| 2021-12-31 | $2.00B | $0.15B | 7.46% |
| 2021-09-30 | $1.82B | $0.14B | 7.52% |
| 2021-06-30 | $1.65B | $0.16B | 9.82% |
| 2021-03-31 | $1.46B | $0.18B | 12.14% |
| 2020-12-31 | $1.37B | $0.15B | 10.88% |
| 2020-09-30 | $1.36B | $0.13B | 9.67% |
| 2020-06-30 | $1.43B | $0.10B | 7.08% |
| 2020-03-31 | $1.51B | $0.05B | 3.11% |
| 2019-12-31 | $1.51B | $0.04B | 2.72% |
| 2019-09-30 | $1.49B | $0.04B | 2.49% |
| 2019-06-30 | $1.44B | $0.03B | 2.23% |
| 2019-03-31 | $1.42B | $0.04B | 2.89% |
| 2018-12-31 | $1.39B | $0.05B | 3.75% |
| 2018-09-30 | $1.13B | $0.07B | 6.22% |
| 2018-06-30 | $1.19B | $0.07B | 5.62% |
| 2018-03-31 | $1.26B | $0.07B | 5.57% |
| 2017-12-31 | $1.32B | $0.06B | 4.86% |
| 2017-09-30 | $1.26B | $0.07B | 5.48% |
| 2017-06-30 | $1.26B | $0.08B | 6.19% |
| 2017-03-31 | $1.25B | $0.09B | 6.96% |
| 2016-12-31 | $1.23B | $0.10B | 7.87% |
| 2016-09-30 | $1.45B | $0.05B | 3.10% |
| 2016-06-30 | $1.42B | $0.04B | 2.89% |
| 2016-03-31 | $1.44B | $0.05B | 3.47% |
| 2015-12-31 | $1.48B | $0.06B | 4.26% |
| 2015-09-30 | $1.67B | $0.12B | 7.06% |
| 2015-06-30 | $1.60B | $0.11B | 6.93% |
| 2015-03-31 | $1.53B | $0.10B | 6.48% |
| 2014-12-31 | $1.40B | $0.08B | 5.66% |
| 2014-09-30 | $1.22B | $0.06B | 4.59% |
| 2014-06-30 | $1.19B | $0.06B | 4.80% |
| 2014-03-31 | $1.13B | $0.05B | 4.69% |
| 2013-12-31 | $1.12B | $0.05B | 4.81% |
| 2013-09-30 | $1.13B | $0.06B | 4.94% |
| 2013-06-30 | $1.14B | $0.05B | 4.67% |
| 2013-03-31 | $1.13B | $0.05B | 4.08% |
| 2012-12-31 | $1.11B | $0.04B | 3.62% |
| 2012-09-30 | $1.06B | $0.04B | 3.67% |
| 2012-06-30 | $1.02B | $0.04B | 3.93% |
| 2012-03-31 | $0.98B | $0.05B | 4.72% |
| 2011-12-31 | $0.94B | $0.05B | 5.51% |
| 2011-09-30 | $0.92B | $0.06B | 6.10% |
| 2011-06-30 | $0.90B | $0.06B | 6.56% |
| 2011-03-31 | $0.89B | $0.07B | 7.45% |
| 2010-12-31 | $0.88B | $0.07B | 8.30% |
| 2010-09-30 | $0.88B | $0.08B | 8.79% |
| 2010-06-30 | $0.87B | $0.08B | 9.01% |
| 2010-03-31 | $0.84B | $0.08B | 8.97% |
| 2009-12-31 | $0.80B | $0.07B | 8.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.047B | $2.788B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.62 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.63 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |